Marion McCourt

Corporate Officer/Principal chez REGENERON PHARMACEUTICALS, INC. Fortune : 9 M $ au 31/05/2026

Profil

Marion McCourt currently works at Girls On The Run International, as Director and Regeneron Pharmaceuticals, Inc., as Executive Vice President-Commercial from 2021.
Ms. McCourt also formerly worked at AstraZeneca Canada, Inc., as President & Chief Executive Officer from 2011 to 2012, SCYNEXIS, Inc., as Independent Director from 2017 to 2018, CytomX Therapeutics, Inc., as Independent Director from 2017 to 2018, Amgen, Inc., as Vice President-US Commercial Operations from 2013 to 2016, AstraZeneca PLC, as Chief Operating Officer-United States Region from 2011 to 2013, AstraZeneca Pharmaceuticals LP, as Vice President-Managed Markets & Government, Medivation LLC (California), as Chief Operating Officer in 2016, and Sio Gene Therapies, Inc., as President & Chief Operating Officer from 2017 to 2018.
Ms. McCourt received her undergraduate degree from Lafayette College.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
REGENERON PHARMACEUTICALS, INC. 0,01 %	09/12/2025	14 546 ( 0,01 % )	9 M $	31/05/2026

Postes actifs de Marion McCourt

Sociétés	Poste	Début
REGENERON PHARMACEUTICALS, INC.	Corporate Officer/Principal	12/02/2018
Girls On The Run International	Directeur/Membre du Conseil	-

Anciens postes connus de Marion McCourt

Sociétés	Poste	Fin
SCYNEXIS, INC.	Directeur/Membre du Conseil	18/09/2018
CYTOMX THERAPEUTICS, INC.	Directeur/Membre du Conseil	13/06/2018
SIO GENE THERAPIES INC.	President	12/02/2018
MEDIVATION INC	Directeur des opérations	01/09/2016
AMGEN INC.	Corporate Officer/Principal	01/01/2016